This study is comparing Psilocybin with Control for people with Major Depression. Participants receive Psilocybin or Control and complete study visits and assessments.
In United States
Why is this study shown?
This study is directly about Depression.
DepressionDrugA study involving a medication or substance.From 18 Years to 75 Years
This study is comparing Psilocybin (Usona Institute) with placebo for people with Major Depression. Participants receive Psilocybin (Usona Institute) or placebo and complete study visits and assessments.
This study is looking at meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group for people with Treatment Resistant Depression. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at care and outcomes for people with depression. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
This study is looking at whether TMS can help people with depression or Suicide prevention. Participants receive a study treatment and complete follow-up visits and assessments.
In United States
Why is this study shown?
This study is directly about Depression.
Depression, SuicidalityBehavioralFrom 15 Years to 25 Years
This observational study is following people with depression, Suicide prevention, or Hospitalization in Children to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
In United States
Why is this study shown?
This study is directly about Depression.
Depression, SuicidalityDeviceA study involving a tool, app, wearable, test, or medical device.From 14 Years to 18 Years
This study is comparing Active Closed Loop Real Time fMRI Neurofeedback with Sham Comparator: Sham Neurofeedback for people with depression. Participants receive Active Closed Loop Real Time fMRI Neurofeedback or Sham Comparator: Sham Neurofeedback and complete study visits and assessments.
This observational study is following people with depression or Fnirs to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at determine efficacy differences between ALTO-300 and placebo, used adjunctively to an antidepressant, related to patient characteristics for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.